CJC-1295 & Ipamorelin Blend (10mg)

CJC-1295 & Ipamorelin Blend (10mg) Dual Peptide Complex for Growth Hormone and Recovery Research

CJC-1295 & Ipamorelin Blend (10mg) is a synergistic combination of two well-characterized growth hormone secretagogues, designed for research into pituitary stimulation, GH/IGF-1 axis modulation, and tissue regeneration. This blend combines the long-acting effects of CJC-1295 with the fast-acting and selective action of Ipamorelin.

Product Overview Each 10mg vial of lyophilized peptide contains a precise ratio of CJC-1295 and Ipamorelin, manufactured at >99% purity for consistent lab results. Researchers value this blend for its ability to simulate both sustained and pulsatile GH release, ideal for exploring anabolic signaling and endocrine feedback loops.

Key Research Attributes:

• Dual Mechanism of Action: CJC-1295 offers prolonged GH stimulation via DAC modification, while Ipamorelin triggers rapid, pulse-like GH release without affecting cortisol or prolactin.
• Muscle and Tissue Studies: Commonly used in models investigating cellular repair, muscle regeneration, and performance recovery mechanisms.
• Hormonal Balance Exploration: Enables detailed analysis of feedback mechanisms, GH pulse timing, and receptor response modulation.
• Lab-Grade Quality: High-purity formulation ensures dependable reconstitution and data reproducibility in experimental environments.

Applications in Scientific Research

• GH/IGF-1 axis signaling pathway studies
• Growth hormone secretion and endocrine modulation
• Tissue regeneration and cellular recovery models
• Muscle hypertrophy and anabolic response assays
• Comparative analysis of GH secretagogues

Format and Storage Form: Lyophilized powder Purity: >99% Storage: Store at -20°C in a sealed container Reconstitution: Reconstitute using sterile bacteriostatic water for research preparation

Disclaimer: CJC-1295 & Ipamorelin Blend (10mg) is intended for research and laboratory use only. It is not approved for human or veterinary use. All research must comply with institutional and legal requirements.